0001610717-24-000182.txt : 20240322 0001610717-24-000182.hdr.sgml : 20240322 20240322164213 ACCESSION NUMBER: 0001610717-24-000182 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240320 FILED AS OF DATE: 20240322 DATE AS OF CHANGE: 20240322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAMMER ELIZABETH A CENTRAL INDEX KEY: 0001213041 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36485 FILM NUMBER: 24775864 MAIL ADDRESS: STREET 1: 78TH FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARDELYX, INC. CENTRAL INDEX KEY: 0001437402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-7047 MAIL ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: NTERYX INC DATE OF NAME CHANGE: 20080611 4 1 form4.xml X0508 4 2024-03-20 0001437402 ARDELYX, INC. ARDX 0001213041 GRAMMER ELIZABETH A 78TH FOURTH AVENUE WALTHAM MA 02451 true See Remarks true Common Stock 2024-03-20 4 S 0 86000 7.7323 D 312993 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2023. This transaction was executed in multiple trades in prices ranging from $7.65 to $7.92, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Chief Legal and Administrative Officer /s/ Elizabeth Grammer 2024-03-22